British Columbia Investment Management Corp Exact Sciences Corp Transaction History

British Columbia Investment Management Corp

$16 Billion
Q3 2024

A detailed history of British Columbia Investment Management Corp transactions in Exact Sciences Corp stock. As of the latest transaction made, British Columbia Investment Management Corp holds 109,815 shares of EXAS stock, worth $6.63 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

109,815

Previous 34,787 215.68%

Holding current value

$6.63 Million

Previous $1.47 Million 408.99%

% of portfolio

0.05%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$42.43 - $70.83 $3.18 Million - $5.31 Million	75,028 Added 215.68%	109,815 $7.48 Million
Q2 2024 Aug 14, 2024	BUY	$41.33 - $74.26 $546,093 - $981,197	13,213 Added 61.25%	34,787 $1.47 Million
Q1 2024 May 14, 2024	BUY	$56.27 - $73.77 $44,340 - $58,130	788 Added 3.79%	21,574 $1.49 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $259,391 - $332,562	4,392 Added 26.79%	20,786 $1.54 Million
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $21,562 - $32,386	327 Added 2.04%	16,394 $1.12 Million
Q2 2023 Aug 11, 2023	BUY	$62.68 - $95.05 $15,293 - $23,192	244 Added 1.54%	16,067 $1.51 Million
Q1 2023 May 12, 2023	BUY	$47.19 - $70.77 $14,298 - $21,443	303 Added 1.95%	15,823 $1.07 Million
Q4 2022 Feb 10, 2023	SELL	$30.35 - $53.15 $46,981 - $82,276	-1,548 Reduced 9.07%	15,520 $768,000
Q3 2022 Nov 10, 2022	SELL	$31.97 - $49.37 $91,114 - $140,704	-2,850 Reduced 14.31%	17,068 $555,000
Q2 2022 Aug 12, 2022	SELL	$35.61 - $76.23 $238,017 - $509,521	-6,684 Reduced 25.13%	19,918 $785,000
Q1 2022 May 12, 2022	SELL	$57.56 - $82.54 $200,654 - $287,734	-3,486 Reduced 11.59%	26,602 $1.86 Million
Q4 2021 Feb 11, 2022	SELL	$72.5 - $100.68 $112,012 - $155,550	-1,545 Reduced 4.88%	30,088 $2.34 Million
Q3 2021 Nov 12, 2021	BUY	$90.24 - $124.05 $35,825 - $49,247	397 Added 1.27%	31,633 $3.02 Million
Q2 2021 Aug 09, 2021	BUY	$93.66 - $139.27 $486,376 - $723,229	5,193 Added 19.94%	31,236 $3.88 Million
Q1 2021 Apr 30, 2021	SELL	$116.57 - $155.01 $90,691 - $120,597	-778 Reduced 2.9%	26,043 $3.43 Million
Q4 2020 Feb 02, 2021	BUY	$99.61 - $142.12 $84,668 - $120,802	850 Added 3.27%	26,821 $3.55 Million
Q3 2020 Nov 10, 2020	BUY	$72.92 - $102.01 $164,799 - $230,542	2,260 Added 9.53%	25,971 $2.65 Million
Q2 2020 Aug 12, 2020	BUY	$55.75 - $92.75 $426,822 - $710,094	7,656 Added 47.69%	23,711 $2.06 Million
Q1 2020 May 13, 2020	SELL	$37.9 - $104.44 $697,056 - $1.92 Million	-18,392 Reduced 53.39%	16,055 $931,000
Q4 2019 Feb 12, 2020	BUY	$77.66 - $99.74 $1.3 Million - $1.67 Million	16,777 Added 94.95%	34,447 $3.19 Million
Q3 2019 Nov 14, 2019	SELL	$90.37 - $122.49 $606,382 - $821,907	-6,710 Reduced 27.52%	17,670 $1.6 Million
Q2 2019 Aug 12, 2019	BUY	$89.51 - $118.04 $2.18 Million - $2.88 Million	24,380 New	24,380 $2.88 Million

Others Institutions Holding EXAS

# of Institutions

674

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.7B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account

British Columbia Investment Management Corp Exact Sciences Corp Transaction History